Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
POM121 transmembrane nucleoporin like 3, pseudogene (POM121L3P) is a non-coding, nonfunctional genetic sequence with homology to nucleoporin genes. POM121L3P does not produce protein and is classified as a pseudogene in the human genome. Unlike its functional homologs (e.g., POM121), which are nuclear pore complex transmembrane proteins involved in nuclear-cytoplasmic transport, POM121L3P does not have any known biological activity, disease association, or drug interactions[1][3][5][8]. It is primarily catalogued for genomic annotation purposes. POM121L3P differs from functional nucleoporins (e.g., POM121) that play roles in nuclear transport and disease[4]; POM121L3P is explicitly annotated as a pseudogene and does not encode a receptor, enzyme, transporter, or drug target[1][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on POM121 transmembrane nucleoporin like 3, pseudogene (POM121L3P).